BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8998705)

  • 1. [Clinical efficacy of oral dopaminergic agents: new findings].
    Dei Cas L; Metra M; Nodari S; Raccagni D
    Cardiologia; 1995 Dec; 40(12 Suppl 1):131-8. PubMed ID: 8998705
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine agonists for oral use.
    Tarján J
    Ther Hung; 1988; 36(4):182-90. PubMed ID: 2908160
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular and renal action of dopaminergic prodrugs.
    Casagrande C; Merlo L; Ferrini R; Miragoli G; Semeraro C
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S40-59. PubMed ID: 2483441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adrenergic and dopamine receptors.
    Goldberg LI; Rajfer SI
    Hosp Pract (Off Ed); 1985 Jun; 20(6):67-80. PubMed ID: 2861208
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure.
    Goldberg LI
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S21-8. PubMed ID: 2483439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
    van Zwieten PA
    Ned Tijdschr Geneeskd; 1990 Nov; 134(47):2281-4. PubMed ID: 1979426
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failure.
    van Veldhuisen DJ; Girbes AR; de Graeff PA; Lie KI
    Int J Cardiol; 1992 Dec; 37(3):293-300. PubMed ID: 1361484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
    Carey RA; Jacob L
    J Clin Pharmacol; 1989 Mar; 29(3):207-11. PubMed ID: 2566626
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical efficacy of ibopamine in patients with chronic heart failure.
    Metra M; Dei Cas L
    Clin Cardiol; 1995 Mar; 18(3 Suppl I):I22-31. PubMed ID: 7743695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine agonists, a new perspective in cardiovascular therapy?
    Girbes AR; van Veldhuisen DJ; Smit AJ
    Neth J Med; 1991 Aug; 39(1-2):65-71. PubMed ID: 1683693
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
    Casagrande C; Merlo L; La Regina A
    J Auton Pharmacol; 1990; 10 Suppl 1():s85-93. PubMed ID: 1983011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating chronic heart failure: time to take stock.
    Niebauer J; Coats AJ
    Lancet; 1997 Apr; 349(9057):966-7. PubMed ID: 9100617
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine receptors: applications in clinical cardiology.
    Goldberg LI; Rajfer SI
    Circulation; 1985 Aug; 72(2):245-8. PubMed ID: 2860983
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopaminergic drugs in the management of chronic heart failure.
    Pouleur H; Raigoso J; Rousseau MF
    Eur Heart J; 1991 Aug; 12 Suppl C():29-34. PubMed ID: 1680685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor systems involved in norepinephrine release in heart failure: focus on dopaminergic systems.
    Francis GS
    Clin Cardiol; 1995 Mar; 18(3 Suppl I):I13-6. PubMed ID: 7743693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of mild heart failure: the place of diuretics and ibopamine.
    Van Veldhuisen DJ
    Eur Heart J; 1997 May; 18(5):712-4. PubMed ID: 9152639
    [No Abstract]   [Full Text] [Related]  

  • 17. Long term administration of dopamine: is there a development of tolerance?
    Braun GG; Bahlmann F; Brandl M; Knoll R
    Prog Clin Biol Res; 1989; 308():1097-9. PubMed ID: 2550954
    [No Abstract]   [Full Text] [Related]  

  • 18. [Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
    Campa PP; Puddu PE; Schiariti M; Monti F; Dawodu AA; Gentile C; Lilla Della Monica PL; Vaccaro M; De Biase L
    Cardiologia; 1995 Dec; 40(12 Suppl 1):139-50. PubMed ID: 8998706
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine, cardiovascular dopamine receptors and chronic heart failure.
    Brodde OE
    Cardiologia; 1995 Dec; 40(12 Suppl 1):125-9. PubMed ID: 8903050
    [No Abstract]   [Full Text] [Related]  

  • 20. Agonist or levodopa for Parkinson disease? Ultimately, it doesn't matter; neither is good enough.
    Montgomery EB
    Neurology; 2009 Jun; 72(24):2137; author reply 2137-8. PubMed ID: 19528526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.